Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #96943

Rosalba Ruiz, MD MPH, Binational Coordinator US- Mexico Border Diabetes Prevention and Control Project, Pan American Health Organization, 5400 Suncrest Drive, Suite C-4, El Paso, TX 79912, 915 845 5950 ext 37, ruizrosa@fep.paho.org, Rita Diaz-Kenney, MPH, RD, LD, Division of Diabetes Translation, Center for Disease Control and Prevention, 4770 Buford Highway, NE, Atlanta, GA 30341-3724, Gloria Beckles, MPH PhD, Diabetes Translation, Centers for Disease Control And Prevention, 4700 Buford Hwy. NE MAilstop K, Atlanta, GA 30341, Agustin Lara, MD MPH, Director del Programa de Salud en el Adulto y el Anciano, Secretaría de Salud de México, Benjamín Franklin 132, 2o. piso. Col. Escandón, CP. 11800, México, Distrito Federal, Mexico, Rodolfo Valdez, PhD, Epidemiologist, Centers for Disease Control And Prevention, 4700 Buford Hwy. NE Mailstop K, Atlanta, GA 30341, Beatriz Apodaca, MD, MPH, US Coordinator US- Mexico Border Diabetes Prevention and Control Project, Pan American Health Organization, 5400 Suncrest Drive, El Paso, TX 79912, and Daniel Gutierrez, MD, MPH, Chief US-Mexico Border Field Office, Pan American Health Organization, 5400 Suncrest Drive, El Paso, TX 79912.

US- Mexico border diabetes prevention and control project: A bi-national collaboration in the fight against diabetes

Objective: This is a joint effort between the United States and Mexico to determine the prevelance of Diabetes among Hispanics living along the US- Mexico border and to reduce the burden of diabetes with the implementation of an intervention pilot study utilizing health care promotoras (community health care workers).

Method: The prevalence diabetes survey was administered from February 2001 to October 2002 to a random, stratified sample of 4,027 individuals representative of the border population 18 years and older. A multi-stage cluster design was followed. The strata included state, county and ethnicity (US). Within each stratum, census tracts and blocks were selected according to population size. Then within the blocks, households and adult household members were selected at random. The survey had 65 questions and also included blood pressure readings, anthropometric measurements, fasting glucose plasma and hemoglobin A1c.

Results; the total US- Mexico border prevalence of type 2 diabetes was 15.7%; 11.4% self-reported and 4.3% undiagnosed diabetes. Pre- diabetes resulted in a 13.9% of the population and more than 60% of the border population is overweight and/or obese. More detailed results will be given during the presentation.

A general overview will be given during the presentation of phase II the intervention pilot study, that will applied in 11 clinics along the US- Mexico Border using promotoras to provide diabetes education in the household to patients with diabetes and their families.

Conclusion: This is the first time that the whole border is consider one epidemiological unit, although coordination is complex this project proves that combine efforts by both countries is possible and can serve as an precedent for future studies

Learning Objectives:

• 1.- Discuss strategies to integrate a diabetes network in a bi-national setting.
• 2.- Describe diabetes risk factors among US- Mexico border residents
• 3.- Recognize the prevalence of diabetes among residents 18 years and older living in the US- Mexico border.

Keywords: Diabetes, Chronic Diseases

Related Web page: www.fep.paho.org

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.

Recorded presentation